MpDS | Wounds vs. eKare inSight Research Utilizzo e statistiche

MpDS| Wounds is a solution designed for the automatic capture of clinical images of pressure ulcers and other wounds. Using only a single device it is possible to obtain a graphical visualisation of the wound evolution over time. Why is MpDS the right solution for you? . Faster wound identification and characterisation . Wound evolution in a graphical view . Validated by health professionals . Developed on the basis of scientific research by the Fraunhofer AICOS on automatic capture of wounds Our application is designed for healthcare professionals, and only they should diagnose and make medical decisions. If you are not a healthcare professional, please do not use this application and seek medical advice.
  • App Store di Apple
  • Gratis
  • Salute e fitness

Classifica degli store

- -

eKare inSight is a comprehensive digital platform for wound assessment, telemedicine, and analytics. Powered by the latest advances in computer vision, inSight delivers accurate and reliable wound measurement within seconds at the point of service. Backed by robust scientific/clinical research, inSight is in use globally across the continuum of care, as well as in multi-center clinical trials. eKare inSight is a CE marked and FDA registered medical device/software. See https://ekare.ai/resource-center/publications/ for our latest publications. Copyright © 2015-2024 eKare Inc. www.ekare.ai
  • App Store di Apple
  • Gratis
  • Settore Medico

Classifica degli store

- -

MpDS | WoundsRanking a confronto con eKare inSight Research

Confronta la tendenza di classifica MpDS | Wounds nei ultimi 28 giorni rispetto a eKare inSight Research

Rank

Nessun dato disponibile

Classifica MpDS | Wounds vs. eKare inSight Research per paese a confronto

Confronta la tendenza di classifica MpDS | Wounds nei ultimi 28 giorni rispetto a eKare inSight Research

Nessun dato da visualizzare

Fai confronti con qualsiasi sito con la nostra prova gratuita

Inizia
MpDS | Wounds VS.
eKare inSight Research

17icembre d, 2024